TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33413515

Group type: EXPERIMENTAL
Intervention: Gelatin sponge impregnated with mixed anti-inflammatory drugs
Number of subjects: 128

Group type: COMPARATOR
Intervention: Saline immersed in gelatin sponge (control)
Number of subjects: 128
Study: 32844217

Group type: EXPERIMENTAL
Intervention: Compressive forearm loading
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonloading controls
Number of subjects: 21
Study: 35473369

Group type: EXPERIMENTAL
Intervention: VPEP-E (Violence Prevention Education Program using Empathy), 8 sessions
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (classroom lectures on violence prevention)
Number of subjects: 101
Study: 32198968

Group type: COMPARATOR
Intervention: Response Adaptive Randomization (RAR)
Number of subjects: 0
Study: 33228560

Group type: EXPERIMENTAL
Intervention: CMV seropositivity
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Age group 11-14 years
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Age group 22-24 years
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Non-white ethnicity
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: EBV seropositivity
Number of subjects: 732

Group type: COMPARATOR
Intervention: Smoking status, occupation, body mass index, and region of England
Number of subjects: 732
Study: 35953474

Group type: EXPERIMENTAL
Intervention: Iclepertin (2, 5, 10, or 25 mg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 32725758

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual CAMHS care
Number of subjects: 22
Study: 33034639

Group type: EXPERIMENTAL
Intervention: Simple daily sweepstakes group
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Deadline sweepstakes group
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Sweepstakes plus deposit contract group
Number of subjects: 805

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 805
Study: 35228163

Group type: EXPERIMENTAL
Intervention: CBT weekly
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CBT twice weekly
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IPT weekly
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IPT twice weekly
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: IPT skills
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Behavioral activation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Autonomous motivation
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Compliance
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Baseline working memory
Number of subjects: 200
Study: 32996689

Group type: EXPERIMENTAL
Intervention: Active dichoptic video game treatment (n = 12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo non-dichoptic game (n = 11)
Number of subjects: 23
Study: 36178734

Group type: EXPERIMENTAL
Intervention: Pomalidomide (POM) capsules, 4 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pomalidomide (POM) capsules with high-fat meals
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pomalidomide (POM) capsules
Number of subjects: 56
Study: 33783392

Group type: EXPERIMENTAL
Intervention: Housing voucher receipt
Number of subjects: 0
Study: 32597030

Group type: EXPERIMENTAL
Intervention: Low energy availability (LEA) at 20 kcal/kg fat-free mass (FFM)/day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Neutral energy availability (NEA) at 45 kcal/kg FFM/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low energy availability (LEA)
Number of subjects: 6
Study: 36235628

Group type: EXPERIMENTAL
Intervention: H2-rich calcium powder (HCP) (1500 mg, containing 2.544 μg of H2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: H2-depleted placebo (1500 mg)
Number of subjects: 10
Study: 34014694

Group type: EXPERIMENTAL
Intervention: Valued Living (ACT-based group)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 135
Study: 32543682

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard Blood Glucose Monitoring (BGM)
Number of subjects: 203
Study: 34726694

Group type: EXPERIMENTAL
Intervention: DHA-HO-RUTF
Number of subjects: 2565

Group type: COMPARATOR
Intervention: S-RUTF
Number of subjects: 2565
Study: 33905487

Group type: EXPERIMENTAL
Intervention: Targeted sequencing approach to monitor transposon polymorphisms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Capture-based assay
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Transposon polymorphisms data integration with gene expression data
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Detailed analysis of 18 polymorphisms in a larger association panel
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Luciferase-based expression assay
Number of subjects: 16
Study: 36375185

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.5 mg (Group M)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine 0.5 µg/kg (Group D)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Morphine 0.5 mg with dexmedetomidine 0.5 µg/kg (Group MD)
Number of subjects: 90
Study: 32738955

Group type: EXPERIMENTAL
Intervention: Cytosponge-TFF3 procedure
Number of subjects: 13514

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 13514
Study: 33217109

Group type: EXPERIMENTAL
Intervention: Metalinguistic training (N=22)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Working memory training (N=19)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Chronological age controls
Number of subjects: 41
Study: 35884739

Group type: EXPERIMENTAL
Intervention: Active stimulation (ALIC/NAcc-DBS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 64
Study: 32816023

Group type: EXPERIMENTAL
Intervention: Transoral robotic surgery
Number of subjects: 9745

Group type: COMPARATOR
Intervention: Nonrobotic surgery
Number of subjects: 9745
Study: 36397441

Group type: EXPERIMENTAL
Intervention: Phototherapy + Bifidobacterium animalis subsp. lactis CP-9 (n=43; 5×10^9 CFU/capsule)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Phototherapy + placebo (n=40)
Number of subjects: 83
Study: 33542168

Group type: EXPERIMENTAL
Intervention: Static Computer Aided Implantology (SCAI)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dynamic Computer Aided Implantology (DCAI)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Free Hand
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cone Beam Computed Tomography (CBCT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intraoral Scan (IOS)
Number of subjects: 15
Study: 32762630

Group type: EXPERIMENTAL
Intervention: Thinopyrum bessarabicum-specific EST-STS markers
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Secale anatolicum-specific EST-STS markers
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: S. anatolicum-specific markers
Number of subjects: 3
Study: 34741731

Group type: EXPERIMENTAL
Intervention: VIR-2218 (50-900 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Active metabolite AS(N-1)3'VIR-2218
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: VIR-2218
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 32958573

Group type: EXPERIMENTAL
Intervention: Unknown nuts during Halloween
Number of subjects: 1390

Group type: EXPERIMENTAL
Intervention: Unknown nuts during Easter
Number of subjects: 1390

Group type: EXPERIMENTAL
Intervention: Peanuts during Halloween
Number of subjects: 1390

Group type: EXPERIMENTAL
Intervention: Peanuts during Easter
Number of subjects: 1390

Group type: COMPARATOR
Intervention: Peanut- or tree-nut-induced anaphylaxis during Christmas, Diwali, Chinese New Year, or Eid al-Adha
Number of subjects: 1390
Study: 33779943

Group type: EXPERIMENTAL
Intervention: Lanreotide
Number of subjects: 305

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 305
Study: 34709720

Group type: EXPERIMENTAL
Intervention: Written Clinical Reasoning Prompt (WCRP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (without using the WCRP)
Number of subjects: 24
Study: 33210752

Group type: EXPERIMENTAL
Intervention: Hypotonic non-electrolyte fluid (glycine 1.5%)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Isotonic electrolyte fluid (Ringer's acetate or 0.9% saline)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both types of fluid
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Non-electrolyte fluid
Number of subjects: 23

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 23
Study: 35012478

Group type: EXPERIMENTAL
Intervention: Continuous (weekly) use of a clinical decision support system (CDSS) for medication optimization.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 0
Study: 32574011

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 1614

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion and Vehicle
Number of subjects: 1614
Study: 35179810

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Esketamine (0.25 mg/kg)
Number of subjects: 61
Study: 34411292

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Anakinra (CACE for adherence >90%)
Number of subjects: 64
Study: 32688208

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional management (CM) protocol
Number of subjects: 110
Study: 36478588

Group type: EXPERIMENTAL
Intervention: Steamed hay
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Haylage
Number of subjects: 43
Study: 33833225

Group type: EXPERIMENTAL
Intervention: Psilocybin (0.17 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 32349977

Group type: EXPERIMENTAL
Intervention: BIA-guided fluid management (BIA and traditional clinical methods)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (only traditional clinical methods)
Number of subjects: 240
Study: 36237885

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral nerve block (TPVB)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (general anesthesia)
Number of subjects: 132
Study: 34011470

Group type: EXPERIMENTAL
Intervention: Workshop (90-minute session of injury prevention strategies)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study: 32809003

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1500 mg), hydrocortisone (50 mg), thiamine (100 mg) every 6 hours for 4 days (n=103)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo in matching volumes (n=102)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Ascorbic acid, corticosteroids, and thiamine
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 34382875

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR) 600 mg intravenously every 24 weeks
Number of subjects: 608
Study: 33587505

Group type: EXPERIMENTAL
Intervention: 10 mg/kg VRC01
Number of subjects: 2701

Group type: EXPERIMENTAL
Intervention: 30 mg/kg VRC01
Number of subjects: 2701

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 2701
Study: 32142491

Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 30 min
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 40 min
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 50 min
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus (PIEB) with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL at intervals of 60 min
Number of subjects: 44
Study: 33933597

Group type: EXPERIMENTAL
Intervention: Rapid spread of ictal fast activity (IFA)
Number of subjects: 45
Study: 32080941

Group type: EXPERIMENTAL
Intervention: Functional enrichment of current forest patches
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Multi-species plantations in previously non-forested patches
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Planting biodiversity-enhancing species
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Planting pest-resistant species
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Planting biodiversity-enhancing species vs. drought-tolerant species
Number of subjects: 3
Study: 36316074

Group type: EXPERIMENTAL
Intervention: Navigate intervention (nurse navigation, systematic monitoring of patient-reported outcomes, physical exercise)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 518
Study: 32081401

Group type: EXPERIMENTAL
Intervention: Gray wolf optimization (GWO) algorithm for optimal sizing of energy storage systems in micro-grids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-stage randomization design (TSRD) for modeling wind power uncertainty
Number of subjects: 0
Study: 32673065

Group type: EXPERIMENTAL
Intervention: Counseling with men (4 sessions)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 102
Study: 34481342

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Sham tape application (placebo group)
Number of subjects: 117

Group type: COMPARATOR
Intervention: No application (control group)
Number of subjects: 117
Study: 35192105

Group type: EXPERIMENTAL
Intervention: 0.25% tanfanercept, twice daily for eight weeks
Number of subjects: 100
Study: 34634064

Group type: EXPERIMENTAL
Intervention: Weekly regret lottery with activity trackers and daily text message reminders
Number of subjects: 40

Group type: COMPARATOR
Intervention: Activity trackers and daily text message reminders (control arm)
Number of subjects: 40
Study: 32271051

Group type: EXPERIMENTAL
Intervention: Stress induction
Number of subjects: 238

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Math anxiety
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Baseline perceived stress
Number of subjects: 238
Study: 33964194

Group type: EXPERIMENTAL
Intervention: Topical Dorema ammoniacum cream
Number of subjects: 49
Study: 33770629

Group type: EXPERIMENTAL
Intervention: Outpatient balloon catheter (n = 205)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Inpatient prostaglandin (n = 243)
Number of subjects: 448
Study: 36280536

Group type: EXPERIMENTAL
Intervention: Study medication (Open Group)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Study medication (Hidden Group)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Study-supervised taper and discontinuation of ineffective antidepressant medication
Number of subjects: 108
Study: 35429191

Group type: EXPERIMENTAL
Intervention: School-based karate intervention
Number of subjects: 388
Study: 33471361

Group type: COMPARATOR
Intervention: Traditional antibiotic therapy (from days 3 to 10 of the menstrual cycle)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Antibiotics and molded sorbent-modified polyvinylpyrrolidone (FSMP) inserted from days 5 to 10
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Antibiotics and FSMP
Number of subjects: 70
Study: 32740576

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injection (≥1 ml per time)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no hyaluronic acid injection)
Number of subjects: 80
Study: 36251313

Group type: EXPERIMENTAL
Intervention: Screened for atrial fibrillation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33369879

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: HIIT + EAA
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: EAA
Number of subjects: 66
Study: 32143630

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Conventional tools (free internet access, pharmaceutical pocket guide, pocket guide antibiotic therapy)
Number of subjects: 166
Study: 36045358

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Fibrin glue (FG)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual haemostasis
Number of subjects: 134
Study: 34740927

Group type: EXPERIMENTAL
Intervention: HOPE intervention (collaborative care mental health intervention)
Number of subjects: 15
Study: 35958808

Group type: EXPERIMENTAL
Intervention: Early comprehensive intervention of skin contact combined with breastfeeding
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (postnatal naked contact, physical examination after late navel severing, routine nursing intervention)
Number of subjects: 300
Study: 33599552

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (n = 16)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (n = 20)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intravitreal anti-VEGF injections (ranibizumab or aflibercept)
Number of subjects: 36
Study: 32481420

Group type: EXPERIMENTAL
Intervention: 0.5% NaOCl + Carisolv III
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% NaOCl
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5.25% NaOCl
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phosphate-buffered saline (PBS)
Number of subjects: 40
Study: 35749864

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Semi-fowler position
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (daily activities)
Number of subjects: 96
Study: 32877722

Group type: EXPERIMENTAL
Intervention: Standard high-calorie, high-fat meal administered via naso-gastro-intestinal tube
Number of subjects: 8
Study: 34487910

Group type: EXPERIMENTAL
Intervention: Video-tailored intervention
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Text-tailored intervention
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 501
Study: 32073501

Group type: COMPARATOR
Intervention: Certified Asthma Educator (AE-C)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs)
Number of subjects: 223
Study: 32996017

Group type: EXPERIMENTAL
Intervention: Universal school-based health promotion intervention program
Number of subjects: 215

Group type: COMPARATOR
Intervention: Attention control curriculum
Number of subjects: 215
Study: 32144895

Group type: EXPERIMENTAL
Intervention: Moderate-dose exercise (8 kcal/kg of body weight per week)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: High-dose exercise (20 kcal/kg of body weight per week)
Number of subjects: 108
Study: 35901476

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 20 mL of bupivacaine (0.25%)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 20 mL of bupivacaine (0.25%) and 100 mg magnesium sulphate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham ESPB (2 mL normal saline)
Number of subjects: 75
Study: 33949201

Group type: COMPARATOR
Intervention: Serum metabolomics and proteins/cytokines
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Metabolomic fingerprints
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pathway analysis of ARDS differentiating metabolites
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Longitudinal tracking of identified pathway metabolites
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Comparison of metabolic profiles
Number of subjects: 135
Study: 32986295

Group type: EXPERIMENTAL
Intervention: 4 × 10^7 autologous expanded mesenchymal stem cells (AdMSCs)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33166905

Group type: EXPERIMENTAL
Intervention: Low Motor Competence (LMC) group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Typically Developing (TD) group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Males with LMC
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Females from both competence groups
Number of subjects: 160
Study: 34406172

Group type: EXPERIMENTAL
Intervention: Vitamin C Solution (VCS)
Number of subjects: 3115

Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate Solution (STS)
Number of subjects: 3115

Group type: COMPARATOR
Intervention: Distilled Water (DW)
Number of subjects: 3115
Study: 33528911

Group type: EXPERIMENTAL
Intervention: (-)-OSU6162 15 mg b.i.d. for 4 weeks, then 30 mg b.i.d. for 4 weeks, then 45 mg b.i.d. for 4 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: (-)-OSU6162
Number of subjects: 33
Study: 35915011

Group type: EXPERIMENTAL
Intervention: Online training in pain measurement using structured scales (e.g., Face Scale for Pain Assessment of Preterm Infants, Japanese version of the Premature Infant Pain Profile)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 64
Study: 34678199

Group type: EXPERIMENTAL
Intervention: Traditional healer-delivered point-of-care HIV testing
Number of subjects: 500

Group type: COMPARATOR
Intervention: Referral to local clinics for HIV testing
Number of subjects: 500
Study: 35413901

Group type: EXPERIMENTAL
Intervention: Computed tomography urography (CTU) with corticomedullary phase (CMP)
Number of subjects: 2195

Group type: COMPARATOR
Intervention: Cystoscopy
Number of subjects: 2195
Study: 34459161

Group type: EXPERIMENTAL
Intervention: Anodal stimulation group
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cathodal stimulation group
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation group
Number of subjects: 15
Study: 36002315

Group type: EXPERIMENTAL
Intervention: Trimetazidine 35 mg twice per day for 3 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 26